Welcome and Opening Remarks

Amy Gutmann, Ph.D. Commission Chair

James Wagner, Ph.D. Commission Vice Chair

Session 1: Ethical Considerations in Cognitive Enhancement

Peter Reiner, V.M.D., Ph.D. Professor, National Core for Neuroethics Kinsmen Laboratory of Neurological Research and Brain Research Centre, Department of Psychiatry University of British Columbia

Rear Admiral Peter J. Delany, Ph.D., LCSW-C Director, Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration

Adrian Raine, Ph.D. Richard Perry University Professor of Criminology, Psychiatry, and Psychology University of Pennsylvania

Nick Bostrom, Ph.D. Professor, Faculty of Philosophy Director, Future of Humanity Institute Director, Programme on the Impacts of Future Technology University of Oxford

Session 2: Direct-to-Consumer Neurotechnology

John Reppas, M.D., Ph.D. Director of Public Policy Neurotechnology Industry Organization

Carlos Peña, Ph.D., M.S. Director, Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health U.S. Food and Drug Administration

Freddie Ann Hoffman, M.D. Chief Executive Officer and Founding Member HeteroGeneity LLC Former Deputy Director, Medicine Staff Office of the Commissioner U.S. Food and Drug Administration

Deven McGraw, J.D., M.P.H., LL.M. Partner, Manatt, Phelps & Phillips, LLP Former Director, Health Privacy Project Center for Democracy and Technology

Session 3: Neuroscience Research – Clinical Innovation and Applications

Steven L. Small, Ph.D., M.D. Stanley van den Noort Professor and Chair, Department of Neurology Professor of Neurobiology and Behavior Professor of Cognitive Sciences Director, Neuroscience Imaging Center University of California, Irvine Professor Emeritus of Neurology, The University of Chicago

Paul J. Ford, Ph.D. Program Director, NeuroEthics Program Education Director, Department of Bioethics Cleveland Clinic Associate Professor, Division of Medicine Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Helen Mayberg, M.D. Professor of Psychiatry, Neurology, and Radiology Dorothy C. Fuqua Chair, Psychiatric Neuroimaging and Therapeutics Emory University School of Medicine

Session 4: Neuroscience Research and Diminished Capacity

Jerry Menikoff, M.D., J.D. Director, Office for Human Research Protections U.S. Department of Health and Human Services

Paul S. Appelbaum, M.D. Elizabeth K. Dollard Professor of Psychiatry, Medicine & Law Director, Division of Psychiatry, Law, and Ethics Director, Center for Research on Ethical, Legal & Social Implications of Psychiatric, Neurologic & Behavioral Genetics Department of Psychiatry Columbia University

Session 5: Roundtable Discussion

Session 5: Roundtable Discussion

Concluding Remarks:
Amy Gutmann, Ph.D.
James Wagner, Ph.D.